August 22, 2016 · STOCK Act disclosure
Senator John Hoeven (Republican-ND) bought Bristol-Myers Squibb Company, a stock transaction, valued at $50,001 - $100,000. The trade took place on August 22, 2016 and was disclosed on August 29, 2016 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.
Bristol-Myers Squibb Company